pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
GADLEN Multiple-CD20
Unspecified Cancer
$STTK
Shattuck Labs, Inc.
0
catalysts
Preclinical
GB-910
Rheumatoid Arthritis
Gbiologics Inc
0
catalysts
Phase 3
GC-5107D
Primary Humoral Immune Deficiencies
GC Biopharma Corp
0
catalysts
Phase 2
GCC-4001
Idiopathic Inflammatory Myopathy (IIM)
← prev
page 5 of 13
next →
131
Pain
89
Neurology
1
$ARTV
Artiva Biotherapeutics, Inc.
0
catalysts
Preclinical
GRI-0803
Systemic Lupus Erythematosus
$GRI
GRI Bio, Inc.
0
catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
Severe Combined Immune Deficiency (SCID)
University of California San Francisco
0
catalysts
Phase 2
Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
X-Linked SCID
Boston Children's Hospital
0
catalysts
Phase 1
HNC-1058
Idiopathic Pulmonary Fibrosis
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Preclinical
HT-KIT
Anaphylaxis
$HOTH
Hoth Therapeutics, Inc.
0
catalysts
Marketed
Haegarda
Haegarda (C1 esterase inhibitor (human))
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
CSL Behring LLC
0
catalysts
Phase 1
IA-14069
Rheumatoid Arthritis
iLab Co Ltd
0
catalysts
Preclinical
ICT-6401
Autoimmune Disorders
Innovative Cellular Therapeutics Co Ltd
0
catalysts
Phase 2
IM-101
Myasthenia Gravis
ImmunAbs Inc
0
catalysts
Preclinical
INB-619
Systemic Lupus Erythematosus
$INAB
IN8BIO, INC.
0
catalysts
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
0
catalysts
Preclinical
Immunology
Unspecified Immunological Disorders
Dawn Sea Therapeutics
0
catalysts
Phase 2
KBLP-001
Plaque Psoriasis (Psoriasis Vulgaris)
KoBioLabs Inc
0
catalysts
Phase 1
KINE-101A
Rheumatoid Arthritis
Kine Sciences
0
catalysts
Preclinical
KPV
Inflammation
PharmaTher Holdings Ltd
0
catalysts
Preclinical
KQ-2512
Systemic Lupus Erythematosus
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Preclinical
LBL-051
Lupus Nephritis
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LCTG-001
Common Variable Immunodeficiency (CVID)
Lactiga Inc
0
catalysts
Phase 2
LIS-1
Kidney Transplant Rejection
Xenothera SAS
0
catalysts
Phase 1
LPXTI-641
Psoriatic Arthritis
Lapix Therapeutics Inc
0
catalysts
Preclinical
MPB-2354
Rheumatoid Arthritis
MegaPro Biomedical Co Ltd
0
catalysts
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVS
NOVARTIS AG
0
catalysts
Phase 1
MRT-8102
Inflammation
$GLUE
Monte Rosa Therapeutics, Inc.
0
catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0
catalysts
Marketed
Mestinon
Mestinon (pyridostigmine bromide)
Myasthenia Gravis
Bausch Health US LLC
0
catalysts
